Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human endothelium: target for aldosterone.

Hans Oberleithner1, Thomas Ludwig, Christoph Riethmüller

  • 1Institute of Physiology II, Nanolab, University Münster, Germany. oberlei@uni-muenster.de

Hypertension (Dallas, Tex. : 1979)
|March 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of cefiderocol during prolonged intermittent kidney replacement therapy in two patients with septic shock.

The Journal of antimicrobial chemotherapy·2026
Same author

A Pitstop-2 analog impairs viability of aggressive lung cancer cells by disrupting nuclear pore integrity.

Nanoscale advances·2025
Same author

Heparan sulfate N-deacetylase/N-sulfotransferase-1 regulates glioblastoma cell migration and invasion.

Matrix biology : journal of the International Society for Matrix Biology·2025
Same author

The potassium channel K<sub>2P</sub>2.1 shapes the morphology and function of brain endothelial cells via actin network remodeling.

Nature communications·2025
Same author

[Predictability of patient disposition from emergency medical services triage categories: exploratory analysis of routine data].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2025
Same author

Direction-dependent contributions of cardiac myofilament networks to myocardial passive stiffness reveal a major disparity for titin.

Basic research in cardiology·2025

Aldosterone causes endothelial cells to swell by affecting ion transport. This aldosterone-induced swelling is blocked by spironolactone and amiloride, suggesting potential medical applications.

Area of Science:

  • Cardiovascular Biology
  • Endocrinology
  • Cell Physiology

Background:

  • Aldosterone regulates electrolyte balance via mineralocorticoid receptors primarily in the kidney.
  • Mineralocorticoid receptors are also present in nonclassical locations, such as the cardiovascular system.
  • Endothelial cells play a critical role in vascular health and function.

Purpose of the Study:

  • To investigate whether endothelial cells respond to aldosterone by altering cell volume.
  • To determine the role of mineralocorticoid receptors and ion channels in aldosterone-mediated endothelial cell volume changes.
  • To explore the potential therapeutic implications of targeting aldosterone's effects on endothelial cells.

Main Methods:

  • Human umbilical venous endothelial cells were cultured and exposed to aldosterone (10 nmol/L) for 72 hours.

Related Experiment Videos

  • Atomic force microscopy was used to measure endothelial cell volume changes in real-time.
  • The effects of mineralocorticoid receptor antagonist spironolactone and sodium channel blocker amiloride on cell volume were assessed.

    • Main Results:

    • Aldosterone induced a significant, sustained swelling (approximately 18%) in endothelial cells over 72 hours.
    • Aldosterone-induced swelling was completely inhibited by the mineralocorticoid receptor antagonist spironolactone.
    • Aldosterone-treated cells exhibited dramatic shrinkage upon application of the diuretic amiloride, indicating amiloride's effect on ion transport in these cells.
    • Cells not exposed to aldosterone did not respond to amiloride, highlighting the necessity of aldosterone priming.

    Conclusions:

    • Aldosterone promotes sustained endothelial cell swelling, mediated by ion transport mechanisms.
    • Spironolactone and amiloride effectively inhibit or reverse aldosterone-induced endothelial cell volume changes.
    • These findings demonstrate that renal diuretics can act on endothelial cells and suggest potential therapeutic roles for amiloride and spironolactone in preventing aldosterone-mediated endothelial dysfunction.